Cool storage volume to be doubled by 2028
·
Third expansion stage of Vetter’s Center for
Visual Inspection and Logistics ·
State-of-the art, fully automated cooled warehouse ·
Plans for additional automated visual inspection
capabilities
Ravensburg, Germany, March 11,
2025 – Vetter, a globally operating Contract Development and
Manufacturing Organization (CDMO), announces a significant expansion of its
pharmaceutical materials warehouse in Ravensburg to meet increasing market
demand and support the company's organic growth. With a further investment of
over €150 million, this expansion will add 16,000 pallet spaces to the existing
13,000 pallet spaces for cool storage. This underlines the company's commitment
to providing innovative and secure storage services. After the expansion,
Vetter will have a total of 68,000 pallet spaces for various temperature
requirements.
“Since the opening of our Center
for Visual Inspection and Logistics in 2012, we have been on a continuous
journey to enhance our storage capabilities for both room temperature and cold
storage,” says Carsten Press, Vetter Managing Director. “The latest phase of
construction marks a strategic step in our warehouse development, driven by the
increasing need for cool chain due to
the many temperature-sensitive medications.”
Groundbreaking for the
warehouse expansion has started in late 2024, with the additional storage space
expected to be operational in 2028. The first milestone is expected in the
fourth quarter of 2026, when the shell of the building will be completed. In
addition to the high-bay warehouse expansion, the new 22,500 sqm building will
house sample storage for stability testing, additional manual and automated
visual inspection rooms, a new staff canteen, and dedicated areas for offices
and a data center.
The newly expanded building
will focus primarily on cold storage, as well as chest and walk-in freezer
capacity, specifically designed for high-profile pharmaceutical products and
associated materials. “The growing need for cool storage for innovative drug
products increases the demand for additional storage space,” explains
Timo Usinger, Senior Vice President Supply Chain Management, Vetter. “As a
result, the new facility will be fully cooled. We are using the latest
automation and digitalization technology, such as advanced monitoring systems
and fully automated pallet storage and retrieval.”
Vetter intends to
continue to play an active role in pharmaceutical storage innovation to meet
the critical supply chain security needs of its global customers and their
patients.
© Vetter Pharma
International GmbH: Rendering of the final stage of the building. The left section illustrates
the current extension.
About Vetter Vetter is a leading Contract Development and Manufacturing
Organization (CDMO) with headquarters in Ravensburg, Germany, and production
facilities in Germany, Austria, and the US. As a global player, the independent
pharmaceutical service provider is also present in the Asia-Pacific markets of
Japan, China, South Korea and Singapore with sales locations. Around the world,
small and large renowned pharma and biotech companies rely on the decades of
experience, high quality, modern technologies, reliability, and commitment of
its more than 7,000 employees. In close partnership with its customers, the
Vetter team supplies patients all over the world with medicines, many of which
are vital. The CDMO provides support from drug product development through
clinical and commercial filling to a wide range of assembly and packaging
services for vials, syringes, and cartridges. With innovative solutions, Vetter
develops prefilled drug-delivery systems together with its customers to
continuously improve patient safety, comfort, and compliance. The company is an
industry pioneer in sustainability and a socially and ethically responsible
corporate citizen. The CDMO is a member of the UN Global Compact and Science
Based Target initiative (SBTi) and received gold status in the renowned
EcoVadis ranking. Multiple awards such as the CDMO Leadership Awards, Frost
& Sullivan Customer Value Leadership Award and the recognition
as Best Managed Company emphasize Vetter’s commitment to sustainable
business. Founded in Ravensburg in 1950, the company remains family-owned to
this day. For more information, visit www.vetter-pharma.com and follow Vetter on LinkedIn.
Contact Vetter Pharma International
GmbH Markus Kirchner Corporate Spokesperson / Media
Relations Eywiesenstrasse 5 88212 Ravensburg Germany Phone: +49 (0)751-3700-3729 E-mail: PRnews@vetter-pharma.com 
